LIFECORE BIOMEDICAL, INC. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $421.00 thousand for the 12-month period ending 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Notes › Receivables › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2019-08-01
- LIFECORE BIOMEDICAL, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2019 was $421.00K, a 815.22% increase from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2018 was $46.00K, a 91.14% decline from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2017 was $519.00K, a 723.81% increase from fiscal 2016.
- LIFECORE BIOMEDICAL, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2016 was $63.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|
| 2019-05-26 | $421.00K 10-K · filed 2019-08-01 |
| 2018-05-27 | $46.00K 10-K · filed 2019-08-01 |
| 2017-05-28 | $519.00K 10-K · filed 2019-08-01 |
| 2016-05-29 | $63.00K 10-K · filed 2018-08-09 |
| 2014-05-25 | $143.00K 10-K · filed 2016-08-01 |
| 2013-05-26 | $109.00K 10-K · filed 2015-07-31 |
| 2012-05-27 | $248.00K 10-K · filed 2014-08-01 |
| 2011-05-29 | $209.00K 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |